New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
New monoclonal antibodies for ALL treatment
What types of post-transplant complications does the biobank project aim to improve?
Regis Peffault de Latour
What we are learning about CLL treatments and the microenvironment
MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia